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S368 Poster Session IIprofessional and ancillary staff as well as various strategies to educate
our patients and their families. These educational strategies included
the creation of falls web site and the creation of fall drills. Qualitative
and quantitative datawere collected and reviewed by amultidisciplin-
ary team and common themes were identified.
Decreasing the rates of falls is crucial to our patient’s physical and
emotional well being, as well as the job satisfaction of our nurses.
Through engaging and empowering all members of the team reduc-
tions in falls rates can bemade in the transplant inpatient population.604
GOOD COLLABORATION
Noteboom, K.1, Taylor, L.2 1Huntsman Cancer Hospital, Salt Lake City,
UT; 2Seattle Cancer Care Alliance, Seattle, WA
Background: Intravenous Busulfan is a core chemotherapy in con-
ditioning for hematopoietic stem cell transplant. Tominimize toxic-
ities from themedication, pharmacokinetic (PK) levelsmay be drawn
and doses adjusted to ensure a ‘‘target’’ level is obtained. Drawing ac-
curate samples depends on precise infusion of the entire dose of che-
motherapy along with obtaining samples at specific time points after
the completion of the infusion. One tertiary care academic medical
center has an established procedure that includes pharmacy pre-
priming chemotherapy tubing with .9% Saline and a closed-system
flush that ensures the entire dose of chemotherapy is infused. Nurs-
ing staff finds this easy to follow and pharmacists do not see unusual
fluctuations in PK levels.
Interventions: Our medical center, in conjunction with a pharma-
ceutical company, started a Phase 2 trial for IV Busulfan. In doing
so, we were given specific instructions for infusion of the chemother-
apy as well as in drawing levels. These instructions included a flush
run at a higher rate than the infusion rate despite a warning from
the manufacturer that rapid infusion is not recommended. As this
is different from the current procedure, nursing staff would be work-
ing with two different procedures for infusion of the chemotherapy.
In order to resolve these questions, the BMT charge nurse at our
medical center consulted with the BMT Clinical Nurse Specialist
at the medical center where PK levels are sent.
Evaluation: The BMT CNS in the medical center being consulted
found that infusion times were inconsistent using the current proce-
dure due to the use of new infusion devices. Consult was also done
with the Pharmacokinetic Laboratory to ensure current practice of
infusion was achieving consistent and accurate samples. As a result
of the collaboration, the procedure was corrected. The procedure
at our medical center was also changed to include the requested in-
structions while on the Phase 2 trial.
Discussion: Collaboration between medical centers has allowed for
improvements in procedures at both institutions that may have not
been discovered without questioning current practices.605
IV COMPATIBILITIES, A JUGGLING ACT
Noteboom, K., Asay, M., Gentner, M., Vinik, K. Huntsman Cancer Hos-
pital, Salt Lake City, UT
Background: The average stem cell transplant patient can have sev-
eral antibiotics, TPN, blood products, and a Patient Controlled An-
algesia running through the IV simultaneously. Nurses at the
University of Utah go to an online database, Micromedex [1], to
check IV compatibilities. Micromedex often does not have oncol-
ogy medications.We found that a printed version is invaluable to the
bedside nurse to find compatibilities.
Purpose: The purpose of this abstract is to share with other oncol-
ogy nurses the value and importance of having a quick reference
manual for IV compatibilities. Having a single reference point for
confirming the compatibility of IVmedications provides consistency
and reliability. The overall goal of the IV compatibility manual is to
enhance patient safety regarding IV medication administration.
Interventions: Three IV compatibility reference manuals were ar-
ranged by the Nurse Educator. The manuals contain relevant drugs
given on a oncology unit. The information provided in the manual is
from the Cancer Chemotherapy Manual [2] and all drugs are alphabet-
ized by generic drug name. As new medications are used, drugs areadded to the manual in collaboration with pharmacy and the Drug
Information Specialist (DIS).
Evaluation: The manual was recently updated from suggestions of
a staff nurse. Staff nurses were unable to find information on Myco-
phenolate in Micromedex. In collaboration with Bone Marrow
Transplant (BMT) pharmacy, Mycophenolate has been added to
the manual. The Mycophenolate information was sent to the DIS
in the hospital with the intent that this information be added to fu-
ture publications. We are also surveying our nurses inquiring if the
manual saves time, issues found, and if the manual enhances patient
safety. Nurses have expressed greater satisfaction with the safety and
time saved of administering IV medications.
Discussion: This is an example of nursing collaborating with phar-
macy to make easy, safe and time saving access to IV drug compati-
bility. As newmedications are added to the BMT, the need for future
compatibility studies will be needed.
[1] Micromedex Healthcare Series, (electronic version). Thom-
son Micromedex, Greenwood Village, Colorado, USA. Available at:
http://www.thomsonhc.com (cited: 01/10/2010).
[2] Beckwith, M.C., Tyler, L.S., eds. Cancer Chemotherapy
Manual. Saint Louis, MO: Facts and Comparison 2010.606
FAST FACTS FLIP CHART – A QUICK ACCESSIBLE REFERENCE GUIDE FOR
BUSY NURSES
Mckinney, T.E., Little, K., Kurtzberg, J., Caraher, B.J. Duke University
Hospital, Durham, NC
Healthcare regulatory bodies, including state boards of nursing
require nursing competencies to be renewed annually to keep the
nurse current and specialized in their individual unit’s nursing prac-
tice. It is imperative to keep skills up to date for safe and effective
nursing delivery. Advancements in the medical science and technol-
ogy have led to an increase need for nurses to be knowledgeable and
competent in more skills. In turn, the increased need to become
trained and retain more skills can lead to overwhelmed nurses.
The Duke Pediatric Blood and Marrow (PBMT) Unit is a highly
specialized critical care unit. Nurses administer over 16,000 medica-
tions and hundreds of blood products monthly. Additionally, nurses
are competent in skills that range from generalmedicine to highly in-
volved transplantation infusions. It can be a challenge to keep nurses
current on practice changes or hospital policy updates. Also, due to
the variety of uncommon diseases treated on the PBMTU, nurses
may not be frequently exposed to certain skill sets. This lapse in
time often results in nurses asking co-workers their opinions on
best practice rather than looking up the correct procedure. In
2009, the PBMTU nursing staff expressed frustration on having to
navigate through the different online portals to find information
about skills and policies. Moreover, it was time consuming when
they needed the information quickly. The Fast Facts flip chart was
created to provide staff quick hands on resource regarding informa-
tion that is pertinent to daily nursing skills. The flip chart hangs at
each nursing station and contains information ranging from infusion
of chemotherapy, tubing and line change parameters to safety checks
regarding blood product administration. It is a quick refresher guide
when the nurse knows the skill but needs affirmation on their knowl-
edge.
Critical care nurses are responsible for being competent on an as-
sortment of nursing skills. Annual competencies alone should not be
the only avenue for keeping nurses current on these skills. There is
a great need for having an easily accessible resource tool available
for nurses. Providing a tool that is current and customized to the
unit’s need will improve safe and competent delivery to the PBMTU
patient population.607
QUALITY OF LIFE PROJECT – AN ORAL PRESENTATION
Caraher, R.B.J., Little, K., Kurtzberg, J., Guess, C., Barfield, R.,
Saini, S., Paul, M.L. Duke University Hospital, Durham, NC
Pediatric patients and families undergoing hematopoietic stem
cell transplantation endure a very intense and complex journeywhich
Poster Session II S369greatly impacts their quality of life. Bedside nurses accompany these
patients and families on this journey and while educating and provid-
ing comfort along the way, these nurses advocate for assistance with
the larger multidisciplinary team to address the patient and family’s
concerns of comfort, quality of life, and possible outcomes.
The PBMTU Quality of Life Project (QoL) was created to em-
power the nurse to better identify, communicate, and assist the fam-
ily’s daily quality of life needs. The goal of the QoL Project is to
improve communication between patients, families, and the multi-
disciplinary medical care team, ensuring that conversations regard-
ing quality of life occur, are conveyed and understood by the entire
team, and a plan is developed which is tailored to that specific patient
and family’s desires. This ensures the path the patient follows is one
that has been fully understood and agreed upon by them and their
family, taking all factors into consideration. In turn, having the entire
medical team updated on the patient’s and families QoL choices
gives the nursing staff relief knowing that these issues have been ad-
dressed and the knowledge to continue caring for the patients effec-
tively and with regard to their specific desires.
TheQoL Project was submitted to the PBMTProgram’s Medical
Director in July 2009. After approval an assessment survey was com-
pleted with the nursing staff in August 2009. The results of the sur-
vey were presented to the entire PBMT Program which generated
many ideas and increased awareness for areas of improvements. After
six months of QoL interventions, in March 2010 the survey was re-
peated. A comparison of the two surveys, review of the interventions
and goals for the future were presented to the medical team in May
2010. The QoL Project was so successful that it has continued to
grow and is having a positive impact on the unit.
The oral presentation will begin with a slide show describing the
history, comparisons the two surveys, interventions, and suggestions
for the future, after which a discussion will take place.608
MANAGEMENT OF NAUSEA AND VOMITING IN THE PEDIATRIC BLOOD
AND MARROW TRANSPLANT SETTING – ARE WE COVERING ALL OF
OUR BASES? A NURSING PERSPECTIVE
Rowland, P. Children’s Healthcare System, Birmingham, AL
The challenge of managing nausea and vomiting (N/V) in the pe-
diatric blood and marrow transplant (BMT) setting is compounded
by multiday chemotherapy/radiation regimens and concomitant
treatments unique to the BMT process. Younger age has been iden-
tified as a particular risk for chemotherapy induced N/V thus in-
creasing the challenge further. An understanding of emetic
pathways affected by these treatments and medications recommen-
ded for each is essential to manage N/V effectively. Several organi-
zations have developed guidelines for antiemetic treatment. Many
recommendations are based on identification and blockage of emetic
pathways. While some organizations briefly address antiemetic rec-
ommendation for the pediatric population, none provide guidelines
for pediatric antiemetic recommendations in the BMT setting.
An evidence based practice group consisting of 13 pediatric BMT
nurses, one data manager, one supportive assistant and one pediatric
BMT nurse practitioner conducted a single institutional chart re-
view. Available medical charts of pediatric patients transplanted at
Alabama’s Childrens Healthcare System between Jan 2008 and April
2010 were reviewed to assess efficacy of N/V management. A com-
parison of treatments to present adult guidelines was completed.
Emetogenic potential for each preparative regimen was graded using
Hesketh’s algorithm for defining emetogenicity of combination reg-
imens. The Common Terminology Criteria for Adverse Events v3.0
(CTCAE) was utilized as a guideline to evaluate severity of daily
N/V.
Results of the chart review prompted a search of literature that
may provide information for treatment of N/V specific to the pedi-
atric population in the BMT setting. There were few articles ad-
dressing concerns of N/V in the pediatric population. It is the
recommendation of the EBP group that focus on research specific
to management of N/V in the pediatric BMT population become
a priority facilitating development of Antiemetic Guidelines specific
to the BMT pediatric population.609
THE POWER OF PROCESS IMPROVEMENT METHODOLOGY ON A HIGHLY
COMPLEX PEDIATRIC BONE MARROW TRANSPLANT UNIT’S CATHETER
ASSOCIATED BLOOD STREAM INFECTION RATES
Flesch, L.1, Demmel, K.M.1, Davies, S.M.1, Nagarajan, R.1,
Hawkins, D.1, Hutchinson, N.2, Bierman, L.1, Fellers, E.1, Hodapp, S.1,
O’Hara, E.1, Shelton, C.1, Curry, C.2, Giesken, R.2, Spear, S.3,
Wheeler, D.2, Giaccone, M.2 1Cincinnati Children’s Hospital Medical
Center, Cincinnati, OH; 2Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH; 3Cincinnati Children’s Hospital Medical Center, Cincin-
nati, OH
Cincinnati Children’sHospitalMedical Center (CCHMC) has in-
stituted a major safety initiative to reduce central venous catheter
(CVC) blood stream infections (BSI). A multidisciplinary approach
utilizing quality improvement methodology was implemented ini-
tially in the PICU, leading to the development of a CVC mainte-
nance bundle.
With the bundle’s success, it was spread to CCHMC’s BMT pro-
gram that had the highest CVC BSI rates. The program, a highly
complex intensive care environment, completed 108 transplants in
2009 with approximately 70% unrelated, 10% matched sibling and
20% autologous. Until this point, line infections were viewed as a di-
rect treatment result leading to mucositis and increased vulnerability
to infection.
Initial support of this initiative was met with much resistance. On-
going communication regarding bundle progress and staff involve-
ment in the initiative through a unit based task force and
a national collaborative resulted in an augmented bundle. A signifi-
cant culture change with acceptance occurred as well. Staff has em-
braced responsibility for overall line infection rates and proactively
identifies infection prevention opportunities.
Ongoing tests of change created an enhanced bundle addressing
the unique challenges of a highly immune compromised population.
The bundle has evolved and includes line entry minimization, daily
line assessment, hand hygiene and site, line, and cap care practices.
The tests included evidence based product changes and review of
catheter and line practices. Specifically, weekly dressing changes,
the use of a biopatch, an occlusive transparent dressing, gloving
with all line care, a 30 second chlorhexidine scrub with every line en-
try, use of a positive pressure cap and masking of all parties during
sterile procedures were additional bundle elements.
CVC BSI rates have changed significantly. In 2006, the rate
reached 6.35 infections per 1000 catheter days. As of June 2010,
the rate was reduced to 1.68 infections per 1000 catheter days result-
ing in a 74% rate reduction.
Table 1. Cincinnati Children’s Hospital Medical Center Bone
Marrow Transplant Unit CVC BSI Rates
CVC BSI Per
FY (July-June) 1000 Line Days2005 5.45
2006 6.35
2007 4.83
2008 4.31
2009 1.98
2010 1.68610
INCREASED MOBILITY AND COMMITMENT TO EXERCISE DURING
HOSPITALIZATION HAS A POSITIVE EFFECT ON OUTCOMES FOR BONE
MARROW TRANSPLANT PATIENTS AT UNIVERSITY OF ALABAMA
HOSPITAL
Howard, R., McCay, W., Dockery, J., Madden, W. UAB, Birmingham,
AL
The Bone Marrow Transplant program staff at the University of
Alabama Hospital used a collaborative partnership approach with
their patients to increase and record physical activity in order to im-
prove clinical outcomes. Participants were encouraged to walk laps
around the unit and record their progress. Exercising in the hallways
